Deletion of exons 4-10 in the IKBKG gene causes incontinentia pigmenti in a Vietnamese child
Author affiliations
DOI:
https://doi.org/10.15625/vjbt-23169Keywords:
Ectodermal dysplastic disorder, gene deletion mutation, IKBKG gene, incontinentia pigmenti, MLPA.Abstract
Incontinentia pigmenti (IP) is an X-linked dominant genetic disorder caused by mutations in the inhibitor of kappa B kinase gamma (IKBKG) gene. Common symptoms of this disease include skin manifestations such as blisters, warty lesions, and hyperpigmentation, as well as skin atrophy and abnormalities in nails, hair, teeth, and the central nervous system. This study aims to identify the pathogenic mutation of a Vietnamese female infant suspected of having IP conditions. Using multiple genotyping methods, including whole-exome sequencing (WES), multiplex ligation-dependent probe amplification (MLPA), and polymerase chain reaction (PCR), we identified that the patient carried a heterozygous deletion encompassing exons 4-10 of the IKBKG gene. This mutation was reported as the most prevalent genetic cause in IP patients worldwide. The patient’s mutation was de novo, as her parents were negative for it. This is the first case of IP reported with the identified genetic etiology in Vietnam and provides valuable information to the Vietnamese population's genetic database of ectodermal dysplastic disorders. Given the high prevalence of the exons 4-10 deletion in the IKBKG gene among IP patients worldwide, we recommend using a low-cost PCR to detect this deletion as the initial screening test for pathogenic mutations in Vietnamese IP patients, followed by sequencing methods if the PCR test is negative.
Downloads
References
Berlin A. L., Paller A. S., & Chan L. S. (2002). Incontinentia pigmenti: A review and update on the molecular basis of pathophysiology. Journal of the American Academy of Dermatology, 47(2), 169–190. https://doi.org/10.1067/mjd.2002.125949
Bodemer C., Diociaiuti A., Hadj-Rabia S., Robert M. P., Desguerre I., Manière M. C. et al. (2020). Multidisciplinary consensus recommendations from a European network for the diagnosis and practical management of patients with incontinentia pigmenti. Journal of the European Academy of Dermatology and Venereology: JEADV, 34(7), 1415–1424. https://doi.org/10.1111/JDV.16403
Cammarata-Scalisi F., Fusco F., & Ursini M. V. (2019). Incontinentia Pigmenti. Actas Dermo-Sifiliográficas (English Edition), 110(4), 273–278. https://doi.org/10.1016/J.ADENGL.2019.03.009
Chen H., Ji X., Lai Y., Xie L., Wan C., & Li L. (2023). Novel IKBKG gene mutations in incontinentia pigmenti: report of two cases. Frontiers in Medicine, 10, 1303590. https://doi.org/10.3389/FMED.2023.1303590/BIBTEX
Courtois G., & Gilmore T. D. (2006). Mutations in the NF-κB signaling pathway: implications for human disease. Oncogene, 25(51), 6831–6843. https://doi.org/10.1038/sj.onc.1209939
Eksambe D., Agim N., Uddin N., Gotway G., & Pascual J. M. (2015). IKBKG mutation with incontinentia pigmenti and ring-enhancing encephalopathy. JAMA Neurology, 72(12), 1533–1535. https://doi.org/10.1001/JAMANEUROL.2015.2795
Fusco F., Bardaro T., Fimiani G., Mercadante V., Miano M. G., Falco G. et al. (2004). Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation. Human Molecular Genetics, 13(16), 1763–1773. https://doi.org/10.1093/HMG/DDH192
Guevara B. E. K., Hsu C. K., Liu L., Feast A., Alabado K. L. P., Lacuesta M. P. M. et al. (2016). Improved molecular diagnosis of the common recurrent intragenic deletion mutation in IKBKG in a Filipino family with incontinentia pigmenti. The Australasian Journal of Dermatology, 57(2), 150–153. https://doi.org/10.1111/AJD.12407
Herlin L. K., Schmidt S. A. J., Mogensen T. H., & Sommerlund M. (2024). Prevalence and clinical characteristics of incontinentia pigmenti: a nationwide population-based study. Orphanet Journal of Rare Diseases, 19(1), 454. https://doi.org/10.1186/S13023-024-03480-8
How K. N., Leong H. J. Y., Pramono Z. A. D., Leong K. F., Lai Z. W., & Yap W. H. (2022). Uncovering incontinentia pigmenti: From DNA sequence to pathophysiology. Frontiers in Pediatrics, 10, 900606. https://doi.org/10.3389/FPED.2022.900606/BIBTEX
Kawai M., Kato T., Tsutsumi M., Shinkai Y., Inagaki H., & Kurahashi H. (2020). Molecular analysis of low-level mosaicism of the IKBKG mutation using the X chromosome inactivation pattern in incontinentia pigmenti. Molecular Genetics & Genomic Medicine, 8(12), e1531. https://doi.org/10.1002/MGG3.1531
Lee N. C., Huang C. H., Hwu W. L., Chien Y. H., Chang Y. Y., Chen C. H. et al. (2009). Pseudogene-derived IKBKG gene mutations in incontinentia pigmenti. Clinical Genetics, 76(4), 417–419. https://doi.org/10.1111/J.1399-0004.2009.01232.X
Ma T. H. T., Luong T. L. A., Hoang T. L., Nguyen T. T. H., Vu T. H., Tran V. K. et al. (2021). Novel and very rare causative variants in the COL7A1 gene of Vietnamese patients with recessive dystrophic epidermolysis bullosa revealed by whole-exome sequencing. Molecular Genetics & Genomic Medicine, 9(8), e1748. https://doi.org/10.1002/MGG3.1748
Minić S., Cerovac N., Novaković I., Gazikalović S., Popadić S., & Trpinac D. (2023). The impact of the IKBKG gene on the appearance of the corpus callosum abnormalities in incontinentia pigmenti. Diagnostics, 13(7), 1300. https://doi.org/10.3390/DIAGNOSTICS13071300/S1
Nguyen H. H., Pham C. M., Nguyen H. T. T., Vu N. P., Duong T. T., Nguyen T. D. et al. (2021). Novel mutations of the PAX6, FOXC1, and PITX2 genes cause abnormal development of the iris in Vietnamese individuals. Molecular Vision, 27, 555. https://pmc.ncbi.nlm.nih.gov/articles/PMC8416135/
Okita M., Nakanishi G., Fujimoto N., Shiomi M., Yamada T., Wataya-Kaneda M. et al. (2013). NEMO gene rearrangement (exon 4-10 deletion) and genotype-phenotype relationship in Japanese patients with incontinentia pigmenti and review of published work in Japanese patients. The Journal of Dermatology, 40(4), 272–276. https://doi.org/10.1111/1346-8138.12091
Puel A., Reichenbach J., Bustamante J., Ku C. L., Feinberg J., Döffinger R. et al. (2006). The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation. American Journal of Human Genetics, 78(4), 691. https://doi.org/10.1086/501532
Song M. J., Chae J. H., Park E. A., & Ki C. S. (2010). The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti. Journal of Korean Medical Science, 25(10), 1513. https://doi.org/10.3346/JKMS.2010.25.10.1513
Steffann J., Raclin V., Smahi A., Woffendin H., Munnich A., Kenwrick S. J. et al. (2004). A novel PCR approach for prenatal detection of the common NEMO rearrangement in incontinentia pigmenti. Prenatal Diagnosis, 24(5), 384–388. https://doi.org/10.1002/PD.889
Wojcik M. H., Clark R. D., Elias A. F., Genetti C. A., Madden J. A., Simpson D. et al. (2025). Long-read sequencing is required for precision diagnosis of incontinentia pigmenti. Human Genetics and Genomics Advances, 6(3). https://doi.org/10.1016/j.xhgg.2025.100468
Downloads
Published
How to Cite
Issue
Section
Funding data
-
Vietnam Academy of Science and Technology
Grant numbers NVCC40.06/25-25
